Veerle Geurts, PhD Candidate at The Netherlands Cancer Institute, shared on LinkedIn:
“Patients with stage I triple negative breast cancer and high TILs have excellent outcome without chemotherapy!
Excited to share our full publication, out now in JAMA oncology.
Thanks to all coauthors!”
Additional information.
Source: Veerle Geurts/LinkedIn